These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28685187)

  • 1. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.
    Kussmann M; Baumann A; Hauer S; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2237-2242. PubMed ID: 28685187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions.
    Wiesholzer M; Winter A; Kussmann M; Zeitlinger M; Pichler P; Burgmann H; Reznicek G; Poeppl W
    Perit Dial Int; 2017 1-2; 37(1):51-55. PubMed ID: 27605684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa.
    Kussmann M; Hauer S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1091-1098. PubMed ID: 29546637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions.
    Kussmann M; Ferth A; Obermüller M; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
    Sci Rep; 2019 Apr; 9(1):6512. PubMed ID: 31019280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of aztreonam in four commercial peritoneal dialysis fluids.
    Tobudic S; Prager I; Kussmann M; Obermüller M; Ursli M; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
    Sci Rep; 2020 Feb; 10(1):1788. PubMed ID: 32019947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility of linezolid with commercial peritoneal dialysis solutions.
    Poeppl W; Rainer-Harbach E; Kussmann M; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Reznicek G
    Am J Health Syst Pharm; 2018 Oct; 75(19):1467-1477. PubMed ID: 30257843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.
    Deslandes G; Grégoire M; Bouquié R; Le Marec A; Allard S; Dailly E; Pineau A; Allain-Launay E; Jolliet P; Roussey G; Navas D
    Perit Dial Int; 2016 11-12; 36(6):676-679. PubMed ID: 27147292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility.
    Ling CW; Sud K; Patel R; Peterson G; Wanandy T; Yeoh SF; Van C; Castelino R
    J Nephrol; 2023 Sep; 36(7):1841-1859. PubMed ID: 37548827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.
    Kussmann M; Schuster L; Zeitlinger M; Pichler P; Reznicek G; Wiesholzer M; Burgmann H; Poeppl W
    Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2257-63. PubMed ID: 26337433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.
    Kussmann M; Schuster L; Wrenger S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
    Perit Dial Int; 2016 11-12; 36(6):662-668. PubMed ID: 27680756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridine levels in ceftazidime - peritoneal dialysis admixtures stored at body temperature.
    Nguyen TT; Harmanjeet H; Wanandy T; Castelino RL; Sud K; Jose MD; Peterson GM; Zaidi STR; Patel RP
    Perit Dial Int; 2020 Mar; 40(2):171-178. PubMed ID: 32063195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacteriological characteristics of the peritoneal dialysis fluid infections].
    Jellouli M; Ferjani M; Abidi K; Hammi Y; Abdallah TB; Gargah T
    Pan Afr Med J; 2015; 22():162. PubMed ID: 26893796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis-related infections recommendations: 2016 update. What is new?
    Liakopoulos V; Nikitidou O; Kalathas T; Roumeliotis S; Salmas M; Eleftheriadis T
    Int Urol Nephrol; 2017 Dec; 49(12):2177-2184. PubMed ID: 28573488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogen spectrum and resistance in patients with peritoneal dialysis-associated peritonitis: A single-center, observational clinical study
.
    Yang L; Gong N; Zhou H; Jiang J
    Clin Nephrol; 2019 Jul; 92(1):44-51. PubMed ID: 31131821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).
    Ranganathan D; Naicker S; Wallis SC; Lipman J; Ratanjee SK; Roberts JA
    Perit Dial Int; 2016; 36(4):421-6. PubMed ID: 26493753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.
    Harmanjeet H; Jani H; Zaidi STR; Wanandy T; Castelino RL; Sud K; Peterson GM; Patel RP
    Perit Dial Int; 2020 Sep; 40(5):470-476. PubMed ID: 32052692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis.
    DePestel DD; Peloquin CA; Carver PL
    Pharmacotherapy; 2003 Oct; 23(10):1322-6. PubMed ID: 14594349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-year analysis of microbial aetiology and antimicrobial sensitivity patterns of peritoneal-dialysis related peritonitis in a tertiary care facility.
    Persy B; Ieven M
    Acta Clin Belg; 2013; 68(1):48-53. PubMed ID: 23627195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of Meropenem and Piperacillin/Tazobactam with Heparin in Various Peritoneal Dialysis Solutions.
    Mendes K; Harmanjeet H; Sedeeq M; Modi A; Wanandy T; Zaidi STR; Ming LC; Castelino RL; Sud K; Peterson GM; Patel RP
    Perit Dial Int; 2018; 38(6):430-440. PubMed ID: 29991562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.